Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Pinzhang Gao"'
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
The DEAD box protein DDX1 is known to form large aggregates in the cytoplasm of early mouse embryos. Here the authors identify DDX1-containing vesicles and show that loss of Ddx1 affects their integrity, compromising mitochondria function and causing
Externí odkaz:
https://doaj.org/article/be6bc66bdfd5409b83301cf498ca5129
Autor:
Jianhua Xu, Yuanzhong Chen, Yong Wu, Meijuan Huang, Pinzhang Gao, Yingjuan Fan, Lisen Huang, Ying Wu, Liguang Lou, Yang Liu, Ruijia Chen, Jing Yu, Lixian Wu
Supplementary Figure S3. Effects of C086 on cell cycle progression.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ddd3150a6f4e849250f0162865b6a02
https://doi.org/10.1158/1078-0432.22459409
https://doi.org/10.1158/1078-0432.22459409
Autor:
Jianhua Xu, Yuanzhong Chen, Yong Wu, Meijuan Huang, Pinzhang Gao, Yingjuan Fan, Lisen Huang, Ying Wu, Liguang Lou, Yang Liu, Ruijia Chen, Jing Yu, Lixian Wu
Supplementary Methods and Materials, Figure Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f91df829edb8ec7a691abf9246b82b6
https://doi.org/10.1158/1078-0432.22459394
https://doi.org/10.1158/1078-0432.22459394
Autor:
Jianhua Xu, Yuanzhong Chen, Yong Wu, Meijuan Huang, Pinzhang Gao, Yingjuan Fan, Lisen Huang, Ying Wu, Liguang Lou, Yang Liu, Ruijia Chen, Jing Yu, Lixian Wu
Purpose: Although tyrosine kinase inhibitors (TKI) such as imatinib provide an effective treatment against Bcr-Abl kinase activity in the mature cells of patients with chronic myelogenous leukemia (CML), TKIs probably cannot eradicate the leukemia st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a5dbdf0b80c36e6009e6099853bf9b2
https://doi.org/10.1158/1078-0432.c.6524213
https://doi.org/10.1158/1078-0432.c.6524213
Autor:
Ruijia Chen, Ying Wu, Lisen Huang, Pinzhang Gao, Yong Wu, Lixian Wu, Mei-juan Huang, Jianhua Xu, Jing Yu, Yuanzhong Chen, Yang Liu, Li-guang Lou, Yingjuan Fan
Publikováno v:
Clinical Cancer Research. 21:833-843
Purpose: Although tyrosine kinase inhibitors (TKI) such as imatinib provide an effective treatment against Bcr-Abl kinase activity in the mature cells of patients with chronic myelogenous leukemia (CML), TKIs probably cannot eradicate the leukemia st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3375bf05f5da703718e036e390d0616c
https://doi.org/10.1158/1078-0432.ccr-13-3317
https://doi.org/10.1158/1078-0432.ccr-13-3317